Pharmacokinetics of methylprednisolone and prednisolone after single and multiple oral administration
- PMID: 9505983
- DOI: 10.1002/j.1552-4604.1997.tb04266.x
Pharmacokinetics of methylprednisolone and prednisolone after single and multiple oral administration
Abstract
The pharmacokinetics of methylprednisolone and prednisolone were evaluated in 24 healthy men after oral administration of single and multiple doses for 3 days. For each drug, 6 different administration regimens with doses ranging from 1 to 80-mg of methylprednisolone and 1.25 to 100-mg of prednisolone, and administration intervals ranging from 3 to 24 hours for both were investigated. Plasma was assayed using a normal phase high-performance liquid chromatography (HPLC) method. Methylprednisolone showed linear pharmacokinetics with no apparent dose or time dependency. Prednisolone showed marked dose dependency with higher clearance and volume of distribution for higher doses. This can be explained by its saturable protein binding of plasma, because unbound clearance and unbound volume of distribution were not dose-dependent. After multiple administration, prednisolone showed significant time-dependent pharmacokinetics with increased unbound clearance and increased unbound volume of distribution. Due to the complicated pharmacokinetic properties of prednisolone, it is extremely difficult to determine the dose needed to obtain a desired target concentration. The pharmacokinetics of methylprednisolone are more predictable because methylprednisolone concentrations are proportional to dose, and no determination of plasma protein binding is needed.
Similar articles
-
Pharmacokinetic/pharmacodynamic evaluation of deflazacort in comparison to methylprednisolone and prednisolone.Pharm Res. 1995 Jul;12(7):1096-100. doi: 10.1023/a:1016287104656. Pharm Res. 1995. PMID: 7494809 Clinical Trial.
-
Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects.Br J Clin Pharmacol. 2001 May;51(5):443-50. doi: 10.1046/j.1365-2125.2001.01372.x. Br J Clin Pharmacol. 2001. PMID: 11422002 Free PMC article. Clinical Trial.
-
Monitoring glucocorticoid therapy: a pharmacokinetic approach.Clin Pharmacol Ther. 1990 Oct;48(4):390-8. doi: 10.1038/clpt.1990.167. Clin Pharmacol Ther. 1990. PMID: 2225699
-
[Problems of equivalency points during therapy with glucocorticoids. A comparison of the clinical pharmacokinetics and pharmacodynamics of prednisolone and methylprednisolone].Dtsch Med Wochenschr. 1994 Dec 2;119(48):1671-6. doi: 10.1055/s-2008-1058886. Dtsch Med Wochenschr. 1994. PMID: 7988369 Review. German. No abstract available.
-
Selecting a systemic corticosteroid for acute asthma in young children.J Pediatr. 2003 Feb;142(2 Suppl):S40-4. doi: 10.1067/mpd.2003.25. J Pediatr. 2003. PMID: 12584519 Review.
Cited by
-
Safety and Effectiveness of Oral Methylprednisolone Therapy in Comparison With Intramuscular Adrenocorticotropic Hormone and Oral Prednisolone in Children With Infantile Spasms.Front Neurol. 2021 Dec 22;12:756746. doi: 10.3389/fneur.2021.756746. eCollection 2021. Front Neurol. 2021. PMID: 35002921 Free PMC article.
-
Pharmacokinetics and Pharmacodynamics of Repository Corticotropin Injection Compared With Synthetic ACTH1-24 Depot and Methylprednisolone in Healthy Subjects.Clin Pharmacol Drug Dev. 2022 Apr;11(4):502-515. doi: 10.1002/cpdd.1020. Epub 2021 Sep 15. Clin Pharmacol Drug Dev. 2022. PMID: 34528408 Free PMC article. Clinical Trial.
-
Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cells.J Headache Pain. 2016;17:19. doi: 10.1186/s10194-016-0609-x. Epub 2016 Mar 1. J Headache Pain. 2016. PMID: 26931452 Free PMC article.
-
Comparison of oral versus intravenous steroid in the management of Bell's palsy: a systematic review and meta-analysis of randomized clinical trials.Eur Arch Otorhinolaryngol. 2024 Mar;281(3):1095-1104. doi: 10.1007/s00405-023-08288-z. Epub 2023 Nov 9. Eur Arch Otorhinolaryngol. 2024. PMID: 37940744
-
Immunosuppressive compounds exhibit particular effects on functional properties of human anti-Aspergillus Th1 cells.Infect Immun. 2014 Jun;82(6):2649-56. doi: 10.1128/IAI.01700-14. Epub 2014 Apr 7. Infect Immun. 2014. PMID: 24711569 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical